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Introduction: Thyroidectomy is a common surgery. Routine searching of the recurrent laryngeal nerve 
is the most important strategy to avoid palsy. Neuromonitoring has been recommended to decrease 
recurrent laryngeal nerve palsy.
Objective: To assess if neuromonitoring of recurrent laryngeal nerve during thyroidectomy is cost-
effective in a developing country.
Materials and methods: We designed a decision analysis to assess the cost-effectiveness of recurrent 
laryngeal nerve neuromonitoring. For probabilities, we used data from a meta-analysis. Utility was 
measured using preference values. We considered direct costs. We conducted a deterministic and a 
probabilistic analysis.
Results: We did not find differences in utility between arms. The frequency of recurrent laryngeal nerve 
injury was 1% in the neuromonitor group and 1.6% for the standard group. Thyroidectomy without 
monitoring was the less expensive alternative. The incremental cost-effectiveness ratio was COP$ 
9,112,065.
Conclusion: Routine neuromonitoring in total thyroidectomy with low risk of recurrent laryngeal nerve 
injury is neither cost-useful nor cost-effective in the Colombian health system.
Key words: Thyroid gland, thyroidectomy, cost-benefit analysis, meta-analysis.
doi: http://dx.doi.org/10.7705/biomedica.v35i3.2371
Análisis económico de la monitorización neurológica rutinaria del nervio laríngeo recurrente en 
la tiroidectomía total
Introducción. La tiroidectomía es una cirugía común. La búsqueda rutinaria del nervio laríngeo inferior 
es la estrategia más importante para evitar la parálisis.
Objetivo. Evaluar el costo-efectividad en un país en desarrollo de la monitorización neurológica del 
nervio laríngeo inferior durante la tiroidectomía.
Materiales y métodos. Se diseñó un análisis de decisiones para evaluar el costo-efectividad de la 
monitorización neurológica del nervio laríngeo inferior. Para las probabilidades se usaron datos de un 
metaanálisis. La utilidad se determinó con medidas de preferencia. Se incluyeron los costos directos. 
Se hizo un análisis determinístico y probabilístico. 
Resultados. No se encontraron diferencias en la utilidad entre las estrategias. La frecuencia de la 
lesión de este nervio fue de 1 % en el grupo bajo monitorización neurológica y de 1,6 % en el grupo 
de control. La tiroidectomía sin monitorización fue la alternativa menos costosa. La razón de costo-
efectividad incremental fue de COP$ 9.112.065
Conclusión. La monitorización neurológica rutinaria en la tiroidectomía total con bajo riesgo de 
lesión del nervio laríngeo inferior, no es útil con relación a su costo ni costo-efectiva en el sistema 
de salud colombiano. 
Palabras clave: glándula tiroides, tiroidectomía, análisis costo-beneficio, metanálisis.
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Thyroidectomy is the most common endocrine 
surgery worldwide. Improvements in surgical tech-
nique have decreased the risk of injury to the 
laryngeal nerves and parathyroid glands (1,2). One 
of the most important complications is recurrent 
laryngeal nerve (RLN) injury. Most injuries are 
unilateral, temporary and improve in a few weeks 
after surgery. However, some injuries are bilateral 
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and produce dysphonia or acute airway obstruction, 
thus requiring a tracheostomy, with a consequent 
loss in quality of life. The frequency of RLN injury, 
which is 1% for most thyroidectomies, can reach 
12% in reoperations (1-3). 
Surgical exploration with routine searching of the 
RLN is the most important strategy to avoid palsy. 
Recently, neuromonitoring has been recommended 
as a novel alternative to further decrease the rate 
of RLN palsy (4). Two published meta-analyses did 
not demonstrate a statistically significant difference 
in the rate of RLN injury (5,6). Nonetheless, some 
authors suggest that its use can be cost-effective 
based on the decrease of sequels (7), but this 
argument has not been tested in the literature or 
the Colombian health system. The aim of this study 
was to assess if routine neuromonitoring of RLN 
during total thyroidectomy is cost-effective in the 
Colombian health system.
Materials and methods
This is a study without risk for patients, so informed 
consent was not necessary. Data confidentiality was 
maintained by assigning a code to each patient. 
We designed a decision analysis study to assess 
the cost-effectiveness and cost-utility of routine 
RLN neuromonitoring during total thyroidectomy. 
The target population was patients who under-
went total thyroidectomy for benign and malignant 
disease. We excluded patients who underwent a 
reoperation or who had previous neck surgery; 
patients with a preoperative RLN injury, as 
demonstrated by clinical dysphonia or direct 
laryngoscopy or a giant goiter; or patients in 
which there was preoperative suspicion of local 
invasion of the trachea or neck vessels, because 
these patients were not included in published 
randomized controlled trials. 
The strategies to be compared were neuro-
monitoring in addition to routine searching of the 
RLN versus routine searching of RLN according 
to the guidelines proposed by the International 
Neural Monitoring Study Group (4). These 
guidelines include the use of a tracheal tube with 
an embedded electrode that acts as a receiver, 
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an electric stimulator and an electromyography 
monitor that records effector muscle activity 
under stimulation. The stimulator, which is used 
to rapidly locate the RLN and assess the integrity 
of the nerve-muscle circuit from the vagus nerve 
before and after dissection, consists of four steps 
(preoperative and postoperative vagus and RLN 
stimulus). The procedure should be stopped if the 
electromyographic signal is lost during unilateral 
stimulation. 
On the following postoperative day, an indirect 
laryngoscopy is conducted to confirm the 
electromyographic findings. If the vocal cord is 
normal, a second surgical procedure to complete 
the thyroidectomy is conducted in the next few 
days, during the same hospital stay. If the vocal 
cord is paralyzed, the conclusion of thyroid-
ectomy is performed after vocal cord mobility is 
recovered. Neuromonitor use is recommended in 
all reoperations. 
The decision tree was built with Treeage Inc. DATA 
4.0 software. For the probabilities of complications, 
we used data from a meta-analysis of randomized 
controlled trials that compared both strategies. The 
utility was measured using preference values which 
are proxy variables for utilities, and the preference 
was considered the value that a surgeon will give 
to an outcome after surgery. This method was 
chosen due to the lack of information about the 
measurement of utilities of the selected outcomes 
with other validated instruments. Effectiveness 
was measured by the number of patients without 
definitive RLN injury. 
We used the payer perspective to measure cost, 
because this device do not offer any long term 
effect on society values, different to those imposed 
in direct medical costs; thus, only direct costs 
were considered. Direct costs included surgeon 
and anesthetist fees, surgical time, length of 
hospital stay, operative resources, reoperation, 
clinical follow-up and the cost of treatment for 
complications. Because complications should be 
followed over the long term, a 5 year time horizon 
was selected, and an annual discount of 3% was 
applied to costs and outcomes. A net present 
value was calculated for utility and costs.
Data analysis
Continuous variables are shown as the mean and 
standard deviation, and discrete variables are 
shown as the frequency and range. We used the 
expected values for decision tree calculations.
365
Biomédica 2015;35:363-71 Neuromonitoring cost-effectiveness in thyroidectomy
We conducted one-way and multiple-way deter-
ministic sensitivity analyses (Tornado analysis) and 
a probabilistic sensitivity analysis assessing the 
rate of unilateral and bilateral RLN palsy, the costs 
of neuromonitoring and utility. One-way analysis 
were made changing only one variable value at a 
time (e.g., rate of RLN injury), while multiple-way 
sensitivity analysis are made changing values of 
all variables simultaneously (e.g., rate of RLN injury, 
intraoperative loss of signal, etc.). The higher and 
lower values used for the sensitivity analysis were 
those reported in the range for each variable. 
Probabilistic sensitivity analysis uses a simulated 
scenario where values of different variables change 
by hazard and the result of each trial is drawn in 
a cost-effectiveness plane. For the probabilistic 
analysis, we assumed a β and triangular distribution 
for categorical variables (e.g., frequency of palsy) 
and a normal and log normal distribution for costs, 
and conducted 1,000 iterations during a Monte 
Carlo simulation. Finally, a worst scenario analysis 
was conducted using cost from the literature and 
information from Gardner, et al. (8), in which a 
unilateral RLN definitive palsy increased costs by 
65% compared to no palsy.
Results
The decision tree was designed following the 
clinical pathway shown in figure 1.
Probabilities
The probabilities of RLN injury were obtained from 
a previous meta-analysis (6). For loss of signal 
probability, we used information from a study by 
Sitges-Serra, et al. (9) (table 1). We assumed 
that the risk of each individual RLN is similar and 
independent of the contralateral nerve because 
neuromonitoring guidelines recommend stopping 
the surgical procedure if a loss of signal occurs 
during the dissection of the first nerve. According 
to this guideline, the risk of bilateral RLN palsy 
corresponds to 1% of all cases of unilateral RLN 
palsy. For probabilistic analysis, characteristics of 
each distribution are shown in table 2.
Utility
We assigned a utility value to each outcome on 
a scale from 1 to 10, corresponding to surgeon 
preference for this outcome. We conducted a 
survey to obtain baseline utility estimates for each 
of the health outcome states, asking to head and 
neck surgeons about the value they gave to each 
state, as described by Kebebew, et al. (10). The 
value of 10 was assigned to the scenario without 
any complications or reoperation. The value of 1 
was assigned to the scenario with RLN definitive 
palsy. A value of 8 was assigned to the situation in 
which there are no complications but reoperation is 
necessary (false positive values of intraoperative 
neuromonitoring), and a value of 5 was assigned 
to situations with no recovery from unilateral palsy 
after neuromonitor surgery (true positives) and 
contralateral uncomplicated surgery (table 3). All 
utility values were adjusted to net present value 
at 5 years.
Effectiveness
Effectiveness was measured as the number of 
patients without nerve injury, assuming a cohort 
of 100 patients.
Costs
We used Colombian pesos to calculate costs (1 US 
dollar = 1,800 Colombian pesos, 2013). The costs 
were obtained using micro-costing from 50 charts 
of patients who underwent a total thyroidectomy 
No complication
No complication
No complication
No complication
Complication
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Loss of signal
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#
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Figure 1. Decision tree 
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by the same surgeon at a tertiary care hospital in 
Colombia. All resources used during the surgical 
procedure were collected using a previously 
designed form. For follow-up, we recorded the 
number of physician visits, medications, vocal 
therapy treatments and procedures to calculate 
an annual value by apportioning according to the 
months of follow-up. The final cost for each patient 
was calculated by multiplying each resource by its 
standard price, which was obtained from a national 
price manual (SOAT 2011) or by searching public 
bids available at government web sites (11). Finally, 
we conducted a Monte Carlo simulation with 500 
iterations to consider cost variations; the mean of 
this simulation was considered to be the mean 
cost, and the upper and lower limits were the 
probable range of costs. 
Table 1. Probabilities for the decision tree (range for sensitivity analysis)
Complications Total thyroidectomy with 
neuromonitor (%, range)
Total thyroidectomy (%)
RLN injury during the first procedure 
RLN injury during reoperation (applies to the 
contralateral nerve)
Intraoperative loss of electromyography signal
Postoperative recovery of electromyography signal 
Risk of tracheostomy
lar_recTT (no loss of signal)
1% (0-10) (6)
lar_rec_reop (loss of signal)
1% (0-10) (6)
loss_of_signal
5% (1-15%)(9)
recover
95%(9)
tracheo
1%
lar-recTT_no monitor signal
1.6% (0.5-10) (6)
RLN: Recurrent laryngeal nerve
Table 2. Characteristics of distribution of probabilities and costs for probabilistic analysis 
Distribution Description Parameters/Information
  1
  2
  3
  4
  5
  6
  7
  8
  9
10
11
12
13
14
15
16
RLN injury TT
RLN injury PT
RLN injury reoperation
Hypocalcemia after TT
Hypocalcemia resulting in reoperation
Reoperation
Utility of reoperation
Loss of signal
Recovery
Cost of TT with no complication
Cost of TT with RLN injury
Cost of HT reoperation with no complication
Cost of HT reoperation unilateral nerve injury
Cost of HT reoperation bilateral RLN injury
RLN injury, no monitoring
Cost of monitoring
Triangular, Min = 0, Likeliest = 0,01, Max = 0,10
Triangular, Min = 0, Likeliest = 0,005, Max = 0,01
Triangular, Min = 0, Likeliest = 0,01, Max = 0,10
Triangular, Min = 0, Likeliest = 0,02, Max = 0,05
Triangular, Min = 0, Likeliest = 0,05, Max = 0,1
Beta, Real-numbered parameters, alpha = 20, beta = 80
Normal, Mean = 5, Std Dev = 3
Beta, Real-numbered parameters, alpha = 5, beta = 95
Beta, Real-numbered parameters, alpha = 95, beta = 5
Log-Normal, u (mean of logs) = 16,37512687, sigma 
(standard deviation of logs) = 0,25
Log-Normal, u (mean of logs) = 16,45456789, sigma 
(standard deviation of logs) = 0,4
Log-Normal, u (mean of logs) = 16,6756472, sigma 
(standard deviation of logs) = 0,4
Log-Normal, u (mean of logs) = 16,70588232, sigma 
(standard deviation of logs) = 0,4
Log-Normal, u (mean of logs) = 18,42818807, sigma 
(standard deviation of logs) = 0,4
Triangular, Min = 0, Likeliest = 0,016, Max = 0,1
Log-Normal, u (mean of logs) = 15,38412648, sigma 
(standard deviation of logs) = 0,4
RLN: Recurrent laryngeal nerve; TT: Total thyroidectomy; PT: Partial thyroidectomy; HT: Hemithyroidectomy 
Table 3. Utility for each intervention 
Value NPV at 5 years
No complication utility
Reoperation without 
complication utility 
Reoperation with unilateral 
loss of signal utility
RLN injury utility
10
  8
  5
  1
(45.80)
(36.64)
(22.90)
  (4.58)
RLN: Recurrent laryngeal nerve; NPV: Net present value
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We could not find cases of bilateral RLN palsy. 
Therefore, we assumed that the cost in this case 
should include a tracheostomy, a three day ICU 
stay with a daily value of COP$ 1,000,000 and an 
additional four day hospital stay for a total value of 
COP$ 10,000,000. For follow-up costs, this patient 
most likely will require pulmonary therapy and tra-
cheostomy care with an additional value of COP$ 
1,000,000/month. This cost represents increase 
of greater than 10 times compared to a patient 
without any complications. For the neuromonitoring 
arm, we used the value of renting a device and 
the value associated with the use of the device. 
We did not consider the capital cost of purchasing 
the equipment because renting is common in 
Colombia. The monitor value was calculated to be 
COP$ 4,800,000 (COP$ 1,500,000 for the tracheal 
tube and COP$ 3,300,000 for renting the monitor). 
According to published guidelines, the monitor 
value was duplicated in cases of reoperation. Table 
4 shows the direct cost values.
Utility analysis
The deterministic analysis did not find differences 
in utility between both arms (44.9 units for the 
monitor vs. 45.1 units without a monitor).
The one-way sensitivity analysis showed that the 
monitor arm has greater utility in cases of RLN 
injury, with a frequency greater than 2.2% in the 
control arm, when the loss of signal frequency 
was lower than 2.5% and the utility assigned to 
reoperation without complication was higher than 9 
units. However, this increase was small (from 45.1 to 
45.8 in utility units) and not clinically significant. The 
rate of RLN injury in reoperation, rate of recovery 
after loss of signal and utility value in reoperation 
with complication did not have any effect on the 
analysis (figure 2). The tornado analysis showed 
that most important variables were RLN injury 
frequency in the control arm, utility of reoperation 
Table 4. Costs of intervention in Colombian pesos (range for sensitivity analysis)
Cost  Total  NPV at 5 years  Lower range  Upper range
Total thyroidectomy without complication
Total thyroidectomy with unilateral RLN injury
Partial thyroidectomy with reoperation 
and without complication
Partial thyroidectomy with reoperation 
and with unilateral RLN injury
Partial thyroidectomy with reoperation 
and bilateral RLN injury
$   2,823,511
$   2,839,363
$   3,813,325
$   3,829,177
$ 22,000,000
$   (12,930,856)
$   (13,003,453)
$   (17,463,913)
$   (17,536,511)
$ (100,753,558)
$   (9,308,176)
$   (7,823,307)
$ (11,632,526)
$ (10,147,657)
$ (50,376,779)
$  (30,822,842)
$  (26,567,286)
$  (31,604,750)
$  (27,349,195)
$(151,130,337)
RLN: Recurrent laryngeal nerve; NPV: Net present value
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Figure 2. Sensitivity analysis for expected utility. A. Probability 
of RLN injury in control arm; B. Probability of loss of signal 
in monitor arm; C. Utility value in reoperation without RLN injury
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many strategies have been designed to avoid RLN 
injury, and the identification and visualization of 
the nerve have demonstrated its utility. Specifically, 
this strategy has demonstrated an RLN injury 
rate lower than 1% in specialized centers (12). 
Many reports have suggested that intraoperative 
neuromonitoring could further decrease the risk 
of RLN injury during thyroid surgery (7,13-16). 
Nonetheless, recent meta-analyses, one of which 
Figure 3. Sensitivity analysis for costs. A. Probability of RLN 
injury in control arm; B. Cost of bilateral RLN injury; C. Cost of 
monitor device 
without complication and loss of signal frequency. 
Therefore, it can be assumed that the utility is 
clinically similar in both strategies.
Effectiveness analysis
The data from the recent meta-analysis showed 
that the frequency of RLN injury was 1% in the 
neuromonitor group and 1.6% for the standard 
group, which was a no significant difference (6).
Cost analysis
In the deterministic analysis, total thyroidectomy 
without a monitor was the less expensive alter-
native (COP$ 12,942,737 vs. COP$ 18,409,976). 
The one way sensitivity analysis showed that 
total thyroidectomy with a monitor dominated all 
possible scenarios (figure 3). The tornado analysis 
showed that most important variables were RLN 
injury frequency in the control arm, bilateral RLN 
injury cost and monitor cost. Therefore, total 
thyroidectomy without a monitor is assumed to be 
less expensive.
Cost-utility and cost-effectiveness analysis
The cost-utility and cost-effectiveness analysis 
results are shown in table 5. For each unit of 
utility, it is necessary to pay COP$ 286.979 in 
the non-monitor strategy compared with COP$ 
410,022 in the monitor arm, with a negative 
incremental cost-utility ratio of COP$ 27,336,195. 
Each effectiveness unit (RLN injury avoided) 
corresponds to COP$ 131,531.88 for the non-
monitor arm compared with COP$ 185,989 
for the monitor arm, with an incremental cost-
effectiveness ratio of COP$ 9,112,065. Therefore, 
total thyroidectomy without a monitor is the best 
strategy in the deterministic analysis.
Figure 4 shows the probabilistic analysis of the 
mean cost-utility for both alternatives. It is clear that 
the incremental cost-utility graph shows that 63% 
of the iterations are located in quadrant II, and most 
iterations are located to the left of one unit of utility, 
representing non-clinically significant differences 
in utility. Figure 5 shows the acceptability curve, in 
which the non-monitor arm is the best option, even 
when COP $ 40,000,000 is the willingness to pay.
The conclusions did not change following the 
assessment of the worst case scenario.
Discussion
Injury of the RLN during total thyroidectomy is a very 
uncommon event that greatly impacts the quality 
of life. Throughout the history of thyroid surgery, 
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Figure 4. Probabilistic cost-utility graph with distribution of 
cost-utility ratios in the cost-effectiveness plane with the 95% 
confidence ellipse 
Figure 5. Acceptability curve 
Table 5. Incremental cost-utility and cost-effectiveness analysis*
Deterministic analysis
Strategy Cost Utility Effectiveness Incremental 
cost
Incremental 
utility
Incremental 
effectiveness
ICUR ICER
TT $12,942,737 45.1 98.4
TT with 
monitor
$18,409,976 44.9 99 $ -5,467,239 0.2 Dominated
(-0.6)
Dominated
($ -27,336,195)
$ 9,112,065
Probabilistic analysis
TT $ 13,381,756 44.1 98.4
TT with 
monitor
$ 19,112,754 43.9 99 $  -5,730,998 0.2 Dominated
(-0.6)
Dominated
($ -28,654,990)
$ 9,551,663
Worst scenario analysis
TT $ 14,028,429 45.1 98,4
TT with 
monitor
$ 19,765,548 44.9 99 $  -5,737,119 0.2 Dominated
(-0.6)
Dominated 
($ -28,685,595)
$ 9,561,865
RLN: Recurrent laryngeal nerve, C/U: Cost-utility ratio, C/E: cost-effectiveness ratio; ICUR: Incremental cost-utility ratio, ICER: Incremental cost-
effectiveness ratio, TT: total thyroidectomy
*The incremental utility and effectiveness was obtained from the substraction TT- TT with monitor.
conducted this study to assess the cost-utility and 
cost-effectiveness of neuromonitoring in Colombia 
(19,20).
It was clear that both alternatives have clinically 
equivalent utility and effectiveness. The lack of 
significant differences in the RLN injury rate demon-
strated in recent meta-analyses and the utility 
analysis in this study indicate that surgeons prefer 
both strategies to a similar extent and demonstrate 
that a new, more expensive device does not offer 
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included observational and experimental studies 
(5) and another that only included randomized 
controlled trials (6), did not find a significant 
difference in RLN injury frequency when comparing 
neuromonitoring with the standard procedure. 
However, some authors still recommend the use of 
neuromonitoring, and the costs of implementation 
are unknown (17,18). Because the cost structure 
cannot be extrapolated across health systems, we 
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clinical advantages in this case. The cases when 
utility was higher for the monitoring arm only 
represented an increase in 0.7 units in a scale of 1 
to 10, which are clinically non-significant.
This study showed that neuromonitoring resulted 
in a dramatic increase in costs due to the large 
impact of the device on cost structure. There was 
an approximately 40% increase in the cost of the 
neuromonitoring alternative, and the lack of cost-
effectiveness was maintained with modifications of 
clinical variables such as the RLN injury frequency 
and the operative characteristics of neuromonitoring 
(loss of signal during the procedure) in the range 
presented. The deterministic analysis showed that 
neuromonitoring was associated with an extra cost 
of almost 27 million Colombian pesos for each 
utility unit gained and nine million Colombian pesos 
for each patient without an RLN injury. These 
data were confirmed in a probabilistic model that 
introduces a random effect into the comparisons and 
showed that most cases with neuromonitoring were 
less cost-effective with a mean incremental cost-
utility ratio of approximately nine million Colombian 
pesos for each utility unit gained. The poor cost-
effectiveness of the use of this device can be 
understood by comparing its costs with the value of 
the total thyroidectomy procedure, including a one 
day stay in the Colombian health system, which 
costs around three million Colombian pesos.
However, it is important to recognize some weak-
nesses that can affect the study conclusions. We 
did not include surgical time in the calculation of 
intraoperative costs. Some authors have shown 
that neuromonitoring can decrease operative time. 
Nonetheless, the decrease in operative time is 
around seven minutes, and we believe that this 
small change does not affect the final conclusions 
(21). Additionally, we only included direct costs and 
payer perspective in the analysis. It is possible that 
a consideration of the societal perspective and 
inclusion of indirect costs can modify the overall 
values, but we believe that the final conclusion 
will not change in the absence of differences in 
effectiveness and utility. It is important to note that 
the target population used in this analysis included 
only total thyroidectomy patients with a low risk 
of RLN injury, such as patients with small thyroid 
glands and without previous neck surgery or local 
invasion. The results of other specific cases could 
be different. Besides, the method to elicit utilities 
was made with a preference scale. It has been 
shown that other methods to measure utilities, as 
validated specific scales, have a better performance 
than analog scales and that utilities measured by 
physicians and normal patients undervalue effects 
on patients. However, the lack of information about 
measurements with specific QOL instruments in 
this type of patients impeded its use in the model. 
Therefore, we believe that utilities values used in 
this model could be even lower and that results 
of cost-utility ratios could be even greater than 
those calculated here (22,23). Finally, costs were 
calculated using the SOAT manual, that could 
overestimate them over other costs sources as 
the ISS manual, but we believe conclusions will 
not change because the greater cost comes from 
a device not included in any manual, with similar 
values for both costs calculation systems. 
Routine neuromonitoring in total thyroidectomy 
with a low risk of RLN injury is neither cost-useful 
nor cost-effective in the Colombian health system, 
and its use introduces an important burden to 
the cost structure of a very common surgical 
procedure. Given that the epidemic of thyroid 
cancers, most of which are asymptomatic, smaller 
than 2 cm and found in young people, corresponds 
to a low risk of nerve injury, the use of routine 
neuromonitoring should not be recommended for 
most patients in Colombia and this results can be 
useful to other developing countries. The cost-
effectiveness of neuromonitoring in cases with 
a high risk of nerve injury should be evaluated 
before making any recommendation.
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